Mean Ankylosing Spondylitis Disease Activity Score (ASDAS) (A)

EULAR Abstract Archive

Disease Control Data, Ankylosing Spondylitis

Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts

ASAS on X: How to measure disease activity in axial spondyloarthritis: the BASDAI / X

SciELO - Brasil - Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort Effectiveness and safety of secukinumab in ankylosing spondylitis and

Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort

Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

The electronic medical record management systems may improve monitoring and control of disease activity in patients with ankylosing spondylitis

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C‐reactive protein (ASDAS‐CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore - Kwan

Clinical Tools to Assess and Monitor Spondyloarthritis

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study - Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd